Activation and Purification of <i>ß</i>‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
Jan Philipp Dobert(Universitätsklinikum Erlangen), Friederike Zunke(Christian-Albrechts-Universität zu Kiel)
Cited by 8
Related Papers
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
|Autophagy|2022|81
Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties
|Frontiers in Cell and Developmental Biology|2021|42
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
|Translational Neurodegeneration|2023|41
Functional Characterization of Colon Cancer-Associated Mutations in ADAM17: Modifications in the Pro-Domain Interfere with Trafficking and Maturation
|International Journal of Molecular Sciences|2019|14
Cryo-TEM structure of β-glucocerebrosidase in complex with its transporter LIMP-2
|Nature Communications|2025|3